INTRODUCTION
============

Chronic kidney disease (CKD) is a strong risk factor for end-stage renal failure and cardiovascular disease \[[@gfw428-B1], [@gfw428-B2]\] and has become an important global public health problem due to its increasing prevalence and mortality \[[@gfw428-B3]\]. Lifestyle-related diseases (e.g. obesity, diabetes and hypertension) are major contributors to the development of CKD, as is low birthweight (LBW) \[[@gfw428-B6]\]. LBW is defined as a birthweight \<2500 g (5.5 lb), irrespective of gestational age, and is associated with a lowered estimated glomerular filtration rate (eGFR), elevated proteinuria and an increased risk of later CKD development \[[@gfw428-B7], [@gfw428-B8]\]. Birthweight is linearly correlated with nephron number \[[@gfw428-B9]\], and kidneys with reduced numbers of nephrons probably have reduced eGFR \[[@gfw428-B10]\], as birthweight is a key determinant of eGFR in young individuals \[[@gfw428-B11]\].

LBW is a global public health problem due to its association with both short- and long-term mortality \[[@gfw428-B14]\], having a global prevalence of 15--20% and occurring in both developing and developed countries \[[@gfw428-B6], [@gfw428-B14], [@gfw428-B15]\]. The proportion of LBW births has increased in most developed countries since 1990 \[15\]. Recently the rate of LBW births in Japan was the highest among the developed countries, showing an increase from ∼5.2% (1980) to 9.6% (2013); the mean rate of LBW births in developed countries was 6.6% (2013) \[[@gfw428-B15]\]. LBW is associated with impaired renal function, therefore a concern regarding the global burden of LBW-related kidney disease exists \[[@gfw428-B6], [@gfw428-B16]\]. However, the actual impact of the serial increase in LBW rates on renal function is currently unknown.

We investigated birthweight and eGFR changes between 1998 and 2015 in healthy Japanese adolescents (15--16 years old). We also examined birthweight category trends to determine the contribution of birthweight changes on renal dysfunction rates.

MATERIALS AND METHODS
=====================

The study included Japanese male high school students attending an annual medical checkup performed by the Health Center, Keio University (Japan). The participants were enrolled in three private high schools in suburban Tokyo. Participants without birthweight data were excluded from this study, but we did not exclude participants known to have pre-existing CKD or hypertension. The study protocol was approved by the review committee of Keio University, the study was conducted in accordance with the Declaration of Helsinki and general informed consent was obtained.

During each medical checkup, each participant's standing height, without shoes, was measured to the nearest centimetre. Body weights were measured to the nearest 100 g, with the participant wearing light clothing. Body mass indexes (BMIs) were calculated using the formula: weight (kg)/\[height (m)\]^2^. Blood pressures (BPs) were measured, after having the participant sit for at least 3 min, using an electronic sphygmomanometer. If the measured BP was \>140/90 mmHg (pre-2011) or \>140/85 mmHg (2011--15), the BP was remeasured. These cut-off values were based on the Japanese Society of Hypertension Guidelines for the Management of Hypertension. If more than one measurement was taken, the average BP was used. The first morning urine specimen was collected and protein levels were determined using a dipstick test. Serum levels of total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), glucose and uric acid (UA) were determined, after overnight fasting, using standard methods. BP, HDL-C, TG and glucose levels were categorized according to the International Diabetes Federation consensus report \[[@gfw428-B17]\]; TC and UA levels were categorized based on previous reports \[[@gfw428-B18], [@gfw428-B19]\]. Increased BMI was defined as a BMI ≥85th percentile; BMI cut-off values for Japanese adolescents \[[@gfw428-B20]\] were used. Serum creatinine (SCr) levels were measured using the modified Jaffe assay until 2000; thereafter, SCr levels were measured using the enzymatic method. Jaffe assay values were converted to enzymatic method values using the following formula: SCr \[enzymatic method (mg/dL)\] = 0.977 × SCr \[Jaffe assay (mg/dL)\]  − 0.199 \[[@gfw428-B21]\]. eGFR was calculated per the following Cr-based equation for Japanese children and adolescents: eGFR = 110.2 × (reference SCr/patient SCr) + 2.93 \[[@gfw428-B22]\]; reference SCr = −1.259 × \[height (m)\]^5 ^+^ ^7.815 × \[height (m)\]^4 ^−^ ^18.57 × \[height (m)\]^3 ^+^ ^21.39 × \[height (m)\]^2 ^−^ ^11.71 × height (m) + 2.628. Regardless of the presence or absence of proteinuria, mildly reduced renal function was defined as an eGFR  ≤ 60-- ≤ 90 mL/min/1.73 m^2^ \[[@gfw428-B23]\].

Birthweight, height and gestational age, recorded at the time of delivery, were obtained from routine obstetric records. Gestational age was available for 2146 study participants.

Statistical analysis
--------------------

Participant characteristics such as eGFR and serum parameters were summarized for three different time periods: 1998--2003, 2004--09 and 2010--15. Data were expressed as means ± SD or proportions; TG values were expressed as medians \[interquartile range (IQR)\]. The prevalence of LBW, high birthweight (HBW, \>4000 g), preterm birth (\<37 weeks), mildly reduced renal function and proteinuria were estimated for each time period. Continuous variable trends over each of the three time periods were assessed using trend tests with two contrasts (linear or plateau at the middle period) in a linear regression model; trends over the years were assessed using simple linear regression. Linear trends of proportions were assessed using the Cochran--Armitage test \[[@gfw428-B24]\]. The odds ratio (OR) for each event was estimated using multivariate logistic regression analysis. To measure the impact of LBW, we calculated the number needed to be exposed (NNE) for one additional adolescent to demonstrate mildly reduced renal function and the population attributable risk (PAR, %) from the adjusted ORs obtained from the multivariate logistic regression analyses \[[@gfw428-B25]\]. Associations between eGFR and potential confounders/mediators were examined using simple linear regression analysis or stepwise multiple linear regression analysis. Age; BP; levels of TG, glucose, HDL-C, UA and TC; BMI; birthweight; and year were taken into account in the multiple regression analysis. If an association was strong, such as between current body weight and BMI, we excluded one of them from the candidate confounders. Multicollinearity was assessed using the variance inflation factor (VIF), and all candidates had VIFs \<1.5. We used a stepwise, bidirectional elimination algorithm, with inclusion and exclusion criteria of P \< 0.20. Each statistical test was two-sided, with a significance level of 5%. All analyses were performed using JMP 12 (SAS Institute, Cary, NC, USA).

RESULTS
=======

Characteristics
---------------

The study involved 3737 male Japanese high school students. Current body weight, birthweight, BP and serum metabolic parameter trends are shown in Table [1](#gfw428-T1){ref-type="table"}; demographics by birthweight category are shown in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}. Current body weight and BMI trends were similar across the three time periods. However, for the participants surveyed in each time period, the mean birthweight decreased from 3213.4 ± 383.8  (1998--2003) to 3116.2 ± 382.3 g (2010--15). Although the proportions of preterm births were not different, the prevalence of LBW increased significantly from 2.5% (1998--2003) to 5.5% (2010--2015) (P ≤ 0.01 for the trend test) (Figure [1](#gfw428-F1){ref-type="fig"}). In each survey period, only one participant was noted to have had a very LBW (VLBW \< 1500 g). A significant decrease in mean eGFR was observed across the survey periods (P ≤ 0.01 for the trend test; Table [1](#gfw428-T1){ref-type="table"}): the mean eGFR was 105.1 ± 15.9 mL/min/1.73 m^2^ during the 1998--2003 period, 99.7 ± 14.1 during the 2004--09 period and 97.4 ± 13.8 during the 2010--15 period. The serum TG level was significantly higher during the 2010--15 period \[56.0 (range 41.0--80.0) mg/dL\] than during the 1998--2003 period \[49.0 (range 36.0--66.0) mg/dL, P ≤ 0.01 for the trend test\]. Although systolic BP values were similar, the diastolic and mean BPs increased significantly across the three time periods. Table 1Demographic, anthropometric and laboratory characteristics of the study population1998--20032004--092010--15(*n* = 1164)(*n* = 1261)(*n* = 1312)Trend test 1Trend test 2Trend test 3P-valueP-valueP-valueHeight (cm)170.6 ± 5.6170.9 ± 5.5170.6 ± 5.70.990.520.99Weight (kg)60.3 ± 8.360.9 ± 8.760.5 ± 8.60.490.150.87BMI (kg/m^2^)20.7 ± 2.520.8 ± 2.620.8 ± 2.50.520.240.94SBP (mmHg)114.8 ± 12.6116.9 ± 13.4113.9 ± 12.90.070.200.07DBP (mmHg)61.5 ± 8.265.9 ± 9.163.1 ± 9.7\<0.01\<0.01\<0.01Mean BP (mmHg)79.2 ± 8.282.8 ± 9.980.0 ± 9.80.047\<0.010.04Cr (mg/dL)0.75 ± 0.100.79 ± 0.100.81 ± 0.10\<0.01\<0.01\<0.01eGFR (mL/min)105.1 ± 15.999.7 ± 14.197.4 ± 13.8\<0.01\<0.01\<0.01TC (mg/dL)169.7 ± 27.6167.3 ± 27.1167.2 ± 26.80.030.010.17TG (mg/dL)[^a^](#tblfn3){ref-type="table-fn"}49.0 (36.0--66.0)52.0 (39.0--75.0)56.0 (41.0--80.0)\<0.01\<0.01\<0.01High-density lipoprotein (mg/dL)63.3 ± 13.265.8 ± 13.462.6 ± 11.60.210.04\<0.01UA (mg/dL)6.1 ± 1.25.9 ± 1.15.9 ± 1.1\<0.01\<0.01\<0.01Glucose (mg/dL)88.7 ± 6.584.8 ± 9.486.0 ± 7.2\<0.01\<0.01\<0.01Birth weight (g)3213.4 ± 383.83170.6 ± 382.73116.2 ± 382.3\<0.01\<0.01\<0.01Gestational age (wk)39.1 ± 1.539.1 ± 1.639.0 ± 1.40.250.290.50[^1][^2][^3]

![LBW, HBW and preterm birth prevalence rates during the 1998--2003, 2004--09 and 2010--15 survey periods. Categorical variables are presented as percentages. LBW, low birthweight (\<2500 g); HBW, high birthweight (\>4000 g); preterm birth, gestational age \<37 weeks.](gfw428f1){#gfw428-F1}

Only one participant had an eGFR \<60 mL/min/1.73 m^2^, reflecting the overall health of the study population. The prevalence of mildly reduced renal function (eGFR ≤ 60-- \< 90 mL/min/1.73 m^2^) increased from 16.4% (1998--2003) to 30.0% (2010--15; P ≤ 0.01 for the trend test) (Figure [2A](#gfw428-F2){ref-type="fig"}). A significant increase in the prevalence of proteinuria from 2.9% (1998--2003) to 6.7% (2010--15; P ≤ 0.01 for the trend test) was also observed (Figure [2B](#gfw428-F2){ref-type="fig"}).

![Prevalence of (**A**) mildly reduced renal function (eGFR ≤ 60-- \< 90 mL/min/1.73 m^2^) and (**B**) proteinuria during the 1998--2003, 2004--09 and 2010--15 survey periods. Categorical variables are presented as percentages.](gfw428f2){#gfw428-F2}

Mildly reduced renal function by birthweight
--------------------------------------------

We examined the prevalence of mildly reduced renal function in each birthweight category to explore its contribution to mildly reduced renal function (Table [2](#gfw428-T2){ref-type="table"}). In the 1998--2003 period, the prevalence of mildly reduced renal function varied from 10.3 to 19.6% across the four birthweight categories. Within each birthweight category, except for HBW, the prevalence of mildly reduced renal function significantly increased across the three time periods and was most evident in the LBW group. The prevalence of mildly reduced renal function among adolescents with birthweights of 3000--3999 g increased in each subsequent time period (P for trend ≤ 0.01); the change from the earliest to latest time period was 12.2% \[95% confidence interval (CI) 8.3--16.2\]. Among adolescents with LBW, the prevalence increased from 10.3% in the 1998--2003 span to 41.7% in 2010--2015 span (P ≤ 0.01 for the trend), a 31.3% (95% CI 15.4--47.2) increase from the original frequency (Table [2](#gfw428-T2){ref-type="table"}). To measure the impact of LBW, we calculated the NNE and PAR. Among adolescents with LBW, the NNE needed to result in an additional case of mildly reduced renal function was low (12.2), confirming that LBW is an important risk factor for mildly reduced renal function in adolescents. Moreover, the PAR of LBW on mildly reduced renal function was 1.8%. These data were comparable with a previous report \[[@gfw428-B26]\]. Table 2Prevalence of mildly reduced renal function based on birthweight category in 1998--2003, 2004--09 and 2010--151998--20032004--092010--15Total change (95% CI)P-value[^a^](#tblfn4){ref-type="table-fn"}Birthweight (g)\<250010.3 (3/29)28.9 (13/45)41.7 (30/72)31.3 (15.4--47.2)[^b^](#tblfn5){ref-type="table-fn"}\<0.012500--299919.6 (58/296)32.9 (117/356)32.8 (136/415)13.2 (6.8--19.6)[^b^](#tblfn5){ref-type="table-fn"}\<0.013000--399915.6 (127/812)20.9 (175/839)27.9 (226/811)12.2 (8.3--16.2)[^b^](#tblfn5){ref-type="table-fn"}\<0.01≥400011.1 (3/27)0 (0/21)14.3 (2/14)3.2 (−25.0 to 18.7)0.98[^4][^5]

Risk for mildly reduced renal function and proteinuria
------------------------------------------------------

We tested the associations between mildly reduced renal function/proteinuria and various risk factors \[[@gfw428-B7], [@gfw428-B28]\] using multiple logistic regression analyses. Increased ORs for mildly reduced renal function were observed in the LBW participants \[OR 1.51 (95% CI 1.00--2.55); P = 0.047\], and for those with birthweights ranging from 2500 to 2999 g \[OR 1.52 (95% CI 1.28--1.81); P ≤ 0.01\] (Table [3](#gfw428-T3){ref-type="table"}, left panel). In addition to birthweight, increased BMIs and high UA levels were strongly associated with mildly reduced renal function (Table [3](#gfw428-T3){ref-type="table"}, left panel); high UA levels were also significantly related to proteinuria (Table [3](#gfw428-T3){ref-type="table"}, right panel). The continuous relationships between kidney function and birthweight, BP and metabolic parameters were also examined using stepwise multiple linear regression analyses ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}). Each 1-kg decrease in birthweight was associated with a 3.45 mL/min/1.73 m^2^ decrease in eGFR (95% CI 2.16--4.74; P ≤ 0.01, model *R*^2^= 0.10), comparable to the association found in a previous study \[[@gfw428-B26]\]. UA levels were negatively associated with eGFR \[coefficient −2.13 (95% CI −2.57 to −1.70); P ≤ 0.01\]. Table 3The OR for mildly reduced renal function and proteinuriaMildly reduced renal functionProteinuriaOR95% CIP-valueOR95% CIP-valueBirthweight (g) \<25001.511.00--2.550.0470.870.36--1.790.73 2500--29991.521.28--1.81\<0.010.860.61--1.200.39 3000--39991.001.00 ≥40000.370.13--0.840.020.640.10--2.110.52Overweight1.601.32--1.95\<0.010.820.54--1.190.30High BP0.800.62--1.030.091.020.64--1.560.94Hypertriglyceridemia0.840.51--1.330.471.420.63--2.860.37Low HDL-C0.650.25--1.440.300.870.14--3.050.85Hyperglycemia0.840.53--1.300.440.420.10--1.130.09Hypercholesterolemia1.080.82--1.400.591.010.60--1.610.97Hyperuricemia1.571.27--1.94\<0.011.541.04--2.210.03[^6][^7]

DISCUSSION
==========

LBW is a global public health problem demonstrating an increasing prevalence in most developed countries \[[@gfw428-B15], [@gfw428-B29]\]. It is also a major contributor to non-communicable diseases and has been reported to be a risk factor for renal dysfunction, raising concern regarding the global burden of LBW-related kidney disease \[[@gfw428-B6], [@gfw428-B16]\]. However, the population impacts of progressive changes in birthweight over time on renal dysfunction are currently unknown. We found that the prevalence of mildly reduced renal function increased from 16.4% (1998--2003) to 30.0% (2010--15), with simultaneous decreases in mean birthweight in our study population. We also found that these outcome trends varied by birthweight category. The increased prevalence of mildly reduced renal function was particularly notable among the LBW participants. Multiple regression analyses demonstrated that LBW remained independently associated with mildly reduced renal function. Proteinuria also increased significantly over time, implying an increase in the renal dysfunction burden in the subject population. Thus this study demonstrates the impact of the serial increase in LBW on renal function.

In Japan, the mean birthweight has been decreasing since the 1980s \[[@gfw428-B30]\] and the proportion of LBW births has been increasing, similar to the observations in many other developed countries \[[@gfw428-B15], [@gfw428-B29]\]. Several factors, such as shorter gestational duration, increased maternal age, parental socio-economic status and multiple fertilizations, have been reported to affect birthweight. Low pre-pregnancy BMI, due to dieting, and low maternal weight gain, due to strict weight management, also seem to be major contributors to the high incidence of LBW births in Japan \[[@gfw428-B31]\]. In this study, the mean birthweight decreased from 3213.7 ± 383.8 g in the 1998--2003 survey (births in 1982--88) to 3116.2 ± 382.3 g in the 1998--2003 survey (births in 1994--2000). Thus a seemingly trivial (100 g) reduction in mean birthweight led to a near-doubling of the proportion of adolescents with mildly reduced renal function (from 16.4 to 30.0% between surveys). Therefore our study suggests that even minor population shifts in birthweight may have significant public health consequences. Overall, ∼6000 of the 1 200 000 Japanese adolescent males (15--16 years old) may be expected to have mildly reduced renal function due to LBW, based on the attributable population \[[@gfw428-B26]\]. The impact of LBW in the Japanese population may be greater, as described in the study limitations below. The prevalence of mildly reduced renal function increased in the later surveys, particularly in adolescents with LBW. This is likely due to the tendency for a birthweight decrease in the LBW group to occur across the surveys and/or for LBW individuals to appear predisposed to renal dysfunction induced by a 'year' factor, as described below. Regarding the OR for mildly reduced dysfunction by birthweight category, we did not find the U-shaped trend shown in a previous study \[[@gfw428-B8]\]. This discrepancy may be because the number of glomeruli increases and glomerular volume decreases until birthweight approaches 3000 g \[[@gfw428-B9]\]; furthermore, HBW is associated with a genetic predisposition for future CKD \[[@gfw428-B8]\].

LBW and the subsequent overnutrition synergistically augment the risk of CKD \[[@gfw428-B6], [@gfw428-B8]\]. In this study, LBW and increased BMI were significantly associated with renal dysfunction (Table [3](#gfw428-T3){ref-type="table"}). In Japan, the prevalence of obesity has increased, with ∼25% of the male population currently being overweight \[[@gfw428-B30]\]. Therefore there is a concern that LBW and subsequent obesity will increase the prevalence of CKD, as is occurring in developing countries \[[@gfw428-B32], [@gfw428-B33]\]. Because the prevalence of CKD, in Japan, has increased significantly over the last three decades \[[@gfw428-B34]\], we suggest that the incidence of CKD will increase further due to the increasing proportion of LBW babies and their increased risk of becoming obese.

The prevalence of mildly reduced renal function in the 2010--15 period was higher than in the 1998−2003 survey among those with birthweights in the 3000--3999 and 2500--2999 g ranges, suggesting that other changes besides birthweight affected these trends. Although multiple logistic regression analyses demonstrated that increased BMIs and UA levels were associated with an increased risk of renal dysfunction, we could not determine any factors associated with the increased prevalence of renal dysfunction. Risk factors for the decreasing eGFR in adolescents have not been fully elucidated \[[@gfw428-B35]\]. Regardless, reductions in physical activity have been recorded in Japan \[[@gfw428-B36]\] and diet composition has changed over time \[[@gfw428-B37]\], potentially affecting the trends in mildly reduced renal function \[[@gfw428-B38], [@gfw428-B39]\]. Japan is a monoethnic society, and socio-economic differences occur to a lesser degree than in the USA or Europe \[[@gfw428-B40]\]. However, socio-economic data, such as parental education and income, were not investigated, therefore we cannot exclude the potential effects of socio-economic status on the observed trends. These speculations need further investigation.

Several limitations impact the interpretation of this study. First, renal function was not measured directly by infusion of exogenous substances, such as inulin; instead, an equation for estimating GFR for Japanese adolescents with CKD \[[@gfw428-B22]\] was used. Although this equation has not been validated in the general population \[[@gfw428-B41]\], and may become less accurate at higher GFR levels, the equation was determined in individuals with GFR \<150 mL/min/1.73 m^2^ \[[@gfw428-B22]\]. Second, SCr conversions were performed to convert between Jaffe assay and enzymatic method values. The differences between these methods may have affected the SCr and eGFR trends. We converted Cr and used the single formula to compare eGFR, which was previously performed \[[@gfw428-B34], [@gfw428-B42]\], because switching from equations may affect the results \[[@gfw428-B43], [@gfw428-B44]\], and the Schwartz formulae are not suitable for Japanese adolescents due to muscle mass \[[@gfw428-B45]\]. Indeed, we still observed a significant reduction in eGFR between 2004--09 and 2010--15, during which time SCr was measured using the enzymatic method. Third, the sensitivity of the serum sample measurement and urine dipstick methods may have changed throughout the surveys. Fourth, although we speculate that trends in our sample population are reflective of Japanese trends, the analysis of data from only three private high schools might limit this generalization. Specifically, the lower prevalence of VLBW observed in our study (0.08%) compared with a national survey (0.5--0.7%) and the lower eGFR associated with adolescents who were VLBW babies compared with those who were LBW babies \[[@gfw428-B26]\] suggest that our results might represent an underestimation of the true effect of birthweight and the exposure impact of LBW on the Japanese population. Finally, this was a cross-sectional study, which limits conclusions on the causality of impaired renal function.

In conclusion, we found that the prevalence of mildly reduced renal function has increased in Japan concurrent with a decrease in the birthweights of healthy Japanese adolescent males. A low eGFR is a significant risk factor for a rapid decrease in eGFR \[[@gfw428-B46], [@gfw428-B47]\], and our findings suggest that adolescents with LBW might be more vulnerable to CKD later in life. Based on the increasing prevalence of LBW babies, we suspect the incidence of CKD will increase in the future.
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[^1]: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate. Values are expressed as mean ± SD.

[^2]: Trend test 1: a trend test with a linear contrast between three time periods; trend test 2: a trend test with a contrast showing a plateau at a middle category between three time periods; trend test 3: linear trend across years.

[^3]: TG values are expressed as median (IQR).

[^4]: Cochran--Armitage trend test.

[^5]: P \< 0.05 for a comparison between 1998--2003 and 2010--15.

[^6]: CI, confidence interval; HDL, high-density lipoprotein; overweight, BMI ≥85th percentile; high blood pressure, BP ≥ 130/85 mmHg; hypertriglyceridemia, TG ≥ 150 mg/dL; low HDL-C, HDL \< 40 mg/dL; hyperglycemia, glucose≥110 mg/dL; hypercholesterolemia, TC ≥ 200 mg/dL; hyperuricemia, UA ≥ 7.0 mg/dL.

[^7]: The OR and 95% CI were determined by logistic regression analysis. Adjusted for age, year, BMI, BP and metabolic parameters.
